tiprankstipranks
Trending News
More News >
BrightPath Biotherapeutics Co.Ltd. (JP:4594)
:4594
Japanese Market

BrightPath Biotherapeutics Co.Ltd. (4594) Revenue

Compare
0 Followers

BrightPath Biotherapeutics Co.Ltd. Revenue

BrightPath Biotherapeutics Co.Ltd. had a revenue of 23.00K in the quarter ending Dec 31, 2023, with -17.86%. This bring the company's revenue in the last twelve months to 118.00K, Increased -97.71%. In the fiscal year ending Dec 31, 2024, BrightPath Biotherapeutics Co.Ltd. had annual revenue of 1.13M with 1473.61% growth.
Revenue (ttm)
118.00K
Revenue Growth
1221.43%
P/S Ratio
6095.55
Revenue/Employee
¥26,976
Employees
42
Market Cap
¥6.91B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
1.13M1.06M+1,573.63%
Dec 31, 2023
72.00K-5.21M+1.36%
Dec 31, 2022
5.28M-10.13M+34.27%
Dec 31, 2021
15.41M12.90M+615.34%
Dec 31, 2020
2.50M-8.80M+22.16%
Dec 31, 2019
11.30M-144.51M+7.25%
Dec 31, 2018
155.81M-198.60M+43.96%
Dec 31, 2017
354.41M-175.20M+66.92%
Dec 31, 2016
529.61M